Myonexus Therapeutics, Inc. logo

Myonexus Therapeutics, Inc.

Myonexus Therapeutics, Inc. operates as a clinical-stage biotechnology company which develops gene therapies for limb-girdle muscular dystrophies (LGMDs).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://myonexustx.com
Founded2017
Disease Focus
Development StageClinical
STOCK CODENon Listed
Address
5061 Cloudberry Pass,OH 43054
New Albany
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/myonexus-therapeutics-inc.” connections=”true” suffix=””]